NCT06920186

Brief Summary

The aim of this study is to evaluate the analgesic efficacy of this quadruple sensory block compared with the currently recommended procedure (adductor canal block + infiltration).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Jan 2026

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Jan 2026Feb 2027

First Submitted

Initial submission to the registry

March 24, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

January 14, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

March 24, 2025

Last Update Submit

January 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient's recovery at H24 as after surgery assessed by the QoR-15 (Quality of Recovery) questionnaire score

    The QoR-15 score at H24 after surgery was compared between the two groups for primary endpoint analysis. The QoR-15 accurately measures postoperative recovery by focusing on 5 key domains: pain, physical comfort, physical independence, psychological support and emotional state. Each item is rated from 0 (unfavorable) to 10 (favorable), with an overall score corresponding to the sum of the score obtained for each item, i.e. a score from 0 (no recovery) to 150 (full recovery).

    From enrollement to the last H24 after surgery

Secondary Outcomes (22)

  • Knee functional assessment

    Hour 0

  • Post operative pain

    Hour 2

  • Post operative pain

    Hour 6

  • Post operative pain

    Hour 12

  • First ambulation

    Hour 12

  • +17 more secondary outcomes

Study Arms (2)

Group 1 of local analgesia protocol (PROSPECT recommandations)

SHAM COMPARATOR

Locoregional analgesia (LRA) protocol n°1 : adductor canal block + surgical infiltration (PROSPECT recommendations)

Procedure: Analgesia

Group 2 of local analgesia protocol (quadri-peripheral nerve block )

EXPERIMENTAL

Locoregional analgesia (LRA) protocol n° 2 : adductor canal block + femoral-cutaneous block + obturator block + IPACK block

Procedure: Analgesia

Interventions

AnalgesiaPROCEDURE

1- Real Adductor canal block + surgical infiltration and sham of femoro-cutaneous block + obturator block + IPACK block with physiological serum

Group 1 of local analgesia protocol (PROSPECT recommandations)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult male or female
  • Patient with signed consent to participate in the study,
  • Patient with uni or bilateral primary gonarthrosis
  • Indication for total knee arthroplasty.

You may not qualify if:

  • History of knee fracture, arthroplasty or osteotomy
  • Known or unknown contraindication to ALR or locoregional anesthesia products
  • Neurological disease, stroke sequelae
  • Mental deficiency or any other reason that may hinder understanding or strict application of the protocol
  • Patient not affiliated to the French social security system
  • Patient under court protection, guardianship or curatorship
  • Pregnant or potentially pregnant women (women of childbearing age without effective contraception)
  • Patient already included in another therapeutic study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpital Privé Claude Galien

Quincy-sous-Sénart, 91480, France

Location

Clinique des Côtes du Rhône

Roussillon, 38150, France

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Analgesia

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Anesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Category 2 Research Involving the Human Person (RIPH 2) : Multi-center (2 sites), prospective, double-blind randomized, open-label study of two parallel groups of patients undergoing total knee arthroplasty according to locoregional analgesia (LRA) protocol : * Group 1: Real adductor canal block + surgical infiltration and sham of femoro-cutaneous block + obturator block + IPACK block with physiological serum * Group 2: Real adductor canal block + femoro-cutaneous block + obturator block + IPACK block and sham of surgical infiltration with physiological serum
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2025

First Posted

April 9, 2025

Study Start

January 14, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations